微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.24% | -51.09% | 68.42% | 99/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.33% | -51.28% | 11.76% | 97/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.19% | -4.8% | -78.83% | 87/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.62% | 7.87% | 22.71% | 56/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.58% | 33.14% | 67.77% | 76/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.73% | 34.48% | 118.4% | 72/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.25% | -1.57% | -76.01% | 80/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.21% | 90.15% | 51.45% | 75/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.44% | 12.05% | 69.46% | 79/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.03% | -19.44% | 59.84% | 85/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.27% | -9.93% | -53.65% | 81/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.74% | -74.56% | -10.75% | 94/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 3.07% | -72.61% | 21.83% | 95/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.52% | -74.07% | 78.72% | 88/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.41% | 2% | -86.91% | 84/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.77% | -44.88% | -3.93% | 49/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 11.21% | 2% | 15.33% | 32/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.72% | -6.54% | -50.26% | 22/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 19.54% | 26.23% | 87.88% | 21/160 | 2.78% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 10.4% | 2% | -32.82% | 14/160 | 5.05% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 15.48% | 50.29% | 50.29% | 29/160 | 7.09% | 奥赛康 | 35% | 行业排名> |
| 2017-12-31 | 10.3% | -38.62% | -38.62% | 48/160 | 9.66% | 奥赛康 | 28.15% | 行业排名> |
| 2016-12-31 | 16.78% | 2% | 2% | 33/160 | 6.33% | 宏源药业 | 21.91% | 行业排名> |